Two Sigma Investments’s Medifast MED Stock Holding History

Two Sigma Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,500	Closed	-$1.36M	–	3663
2021 Q4	$1.36M	Sell	6,500 -2,800	-30%	-$579K	﹤0.01%	2282
2021 Q3	$1.79M	Buy	9,300 +7,700	+481%	+$1.89M	﹤0.01%	2092
2021 Q2	$453K	Sell	1,600 -1,400	-47%	-$379K	﹤0.01%	3188
2021 Q1	$635K	Buy	3,000 +1,500	+100%	+$359K	﹤0.01%	2701
2020 Q4	$295K	Sell	1,500 -4,100	-73%	-$725K	﹤0.01%	2877
2020 Q3	$921K	Buy	+5,600	New	+$922K	﹤0.01%	1820
2020 Q2	–	Sell	-9,100	Closed	-$569K	–	3292
2020 Q1	$569K	Buy	9,100 +6,800	+296%	+$619K	﹤0.01%	1830
2019 Q4	$252K	Sell	2,300 -6,100	-73%	-$590K	﹤0.01%	3302
2019 Q3	$870K	Buy	8,400 +4,900	+140%	+$527K	﹤0.01%	2098
2019 Q2	$449K	Buy	3,500 +1,500	+75%	+$208K	﹤0.01%	2585
2019 Q1	$255K	Buy	+2,000	New	+$254K	﹤0.01%	2699
2018 Q4	–	Sell	-2,000	Closed	-$443K	–	3318
2018 Q3	$443K	Buy	+2,000	New	+$405K	﹤0.01%	2542

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Two Sigma Investments's MED Position: Q1 2026 in Review

Two Sigma Investments increased its Medifast (MED) stake by 321% in Q1 2026, buying an estimated $2.78M and bringing the position to 338,158 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Two Sigma Investments first reported a position in MED in Q3 2013 and has held it in 28 quarters since. The position peaked at $31.6M in Q3 2020. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Two Sigma Investments held 338,158 shares of Medifast worth $3.45M as of Q1 2026.
Two Sigma Investments bought 257,818 Medifast shares in Q1 2026, an estimated $2.78M.
Medifast made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2320 holding.
Two Sigma Investments first reported a position in Medifast in Q3 2013 and has held it in 28 quarters since.
Two Sigma Investments's Medifast position peaked at $31.6M in Q3 2020.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.